Selma Mohammed in Omaha, Nebraska

Additional Medical Specialties Include:
CARDIOVASCULAR DISEASE (CARDIOLOGY)

Medical School: Sorry, her university is not listed
Graduation Year: 2002
The Primary Medical Specialty for Selma Mohammed is listed as: Advanced Heart Failure And Transplant Cardiology
Approximate Years of Experience: 22
PAC (PECOS ID)#: 3678663424
NPI #: 1851504476
NPI Created On: 05/08/2007
NPI Last Updated Listed as: 03/05/2021
Primary Taxonomy Code: 207R00000X
License Number:
MT185144
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• CareFirst BlueChoice, Inc.
• Group Hospitalization and Medical Services Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English,Arabic, Arabic.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Routine ekg using at least 12 leads including interpretation and report
3. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
4. Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days
5. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
6. Evaluation of lower heart chamber assist device with physician analysis
7. New patient office or other outpatient visit, typically 60 minutes
8. Established patient office or other outpatient visit, typically 10 minutes
9. Established patient office or other outpatient, visit typically 25 minutes
10. Established patient office or other outpatient, visit typically 25 minutes
11. Established patient office or other outpatient, visit typically 40 minutes
12. Established patient office or other outpatient, visit typically 40 minutes
13. Initial hospital inpatient care, typically 70 minutes per day
14. Subsequent hospital inpatient care, typically 25 minutes per day
15. Subsequent hospital inpatient care, typically 35 minutes per day
16. Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec